Cysteine sulfinic acid decarboxylase regulation: A role for farnesoid X receptor and small heterodimer partner in murine hepatic taurine metabolism

Hepatology Research

Volumn 44, Issue 10, 2014, Pages E218-E228

  Kerr, Thomas A ^a   Matsumoto, Yuri ^a   Matsumoto, Hitoshi ^a   Xie, Yan ^a   Hirschberger, Lawrence L ^b   Stipanuk, Martha H ^b   Anakk, Sayeepriyadarshini ^c   Moore, David D ^d   Watanabe, Mitsuhiro ^e   Kennedy, Susan ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cornell University ^*  (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Bile acid conjugation; Bile acid metabolism; Nuclear hormone receptors; Taurine synthesis

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE ACID; CARBOXYLYASE; CELL NUCLEUS RECEPTOR; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; COLESTYRAMINE; CYSTEINE SULFINIC ACID DECARBOXYLASE; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; HYPOTAURINE; LIVER X RECEPTOR; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; SMALL HETERODIMER PARTNER; TAURINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME REGULATION; FEEDBACK SYSTEM; GENE EXPRESSION; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84907866229     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12230     Document Type: Article

References (45)

1. Russell DW. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res 2009; 50 (Suppl): S120-125.
2. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731-744.
3. Makishima M, Okamoto AY, Repa JJ etal. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-1365.
4. Parks DJ, Blanchard SG, Bledsoe RK etal. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-1368.
5. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3: 543-553.
6. Lu TT, Makishima M, Repa JJ etal. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-515.
7. Kerr TA, Saeki S, Schneider M etal. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2002; 2: 713-720.
8. Wang L, Lee YK, Bundman D etal. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2002; 2: 721-731.
9. Inagaki T, Choi M, Moschetta A etal. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2: 217-225.
10. Miyata M, Tozawa A, Otsuka H etal. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity. J Pharmacol Exp Ther 2005; 312: 759-766.
11. Park YJ, Qatanani M, Chua SS etal. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 2008; 47: 1578-1586.
12. Kir S, Beddow SA, Samuel VT etal. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 2011; 331: 1621-1624.
13. Kir S, Kliewer SA, Mangelsdorf DJ. Roles of FGF19 in liver metabolism. Cold Spring Harb Symp Quant Biol 2011; 76: 136-144.
14. Fuchs M. Non-alcoholic fatty liver disease: The bile acid-activated farnesoid X receptor as an emerging treatment target. J Lipids 2012; 2012: 934396.
15. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011; 1812: 893-908.
16. Pircher PC, Kitto JL, Petrowski ML etal. Farnesoid X receptor regulates bile acid-amino acid conjugation. J Biol Chem 2003; 278: 27703-27711.
17. Jung D, Inagaki T, Gerard RD etal. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 2007; 48: 2693-2700.
18. Potthoff MJ, Boney-Montoya J, Choi M etal. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metab 2012; 13: 729-738.
19. Ueki I, Roman HB, Valli A etal. Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 2011; 301: E668-684.
20. Dominy JE, Jr, Hirschberger LL, Coloso RM, Stipanuk MH. Regulation of cysteine dioxygenase degradation is mediated by intracellular cysteine levels and the ubiquitin-26 S proteasome system in the living rat. Biochem J 2006; 394: 267-273.
21. Sakakura H, Suzuki M, Kimura N, Takeda H, Nagata S, Maeda M. Simultaneous determination of bile acids in rat bile and serum by high-performance liquid chromatography. J Chromatogr 1993; 621: 123-131.
22. Anakk S, Watanabe M, Ochsner SA, McKenna NJ, Finegold MJ, Moore DD. Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis. J Clin Invest 2011; 121: 86-95.
23. Maloney PR, Parks DJ, Haffner CD etal. Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 2000; 43: 2971-2974.
24. Goodwin B, Jones SA, Price RR etal. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000; 6: 517-526.
25. Holt JA, Luo G, Billin AN etal. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 2003; 17: 1581-1591.
26. Yu C, Wang F, Kan M etal. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem 2000; 275: 15482-15489.
27. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996; 383: 728-731.
28. Peet DJ, Turley SD, Ma W etal. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693-704.
29. Stipanuk MH, Londono M, Lee JI, Hu M, Yu AF. Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J Nutr 2002; 132: 3369-3378.
30. Tappaz ML. Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res 2004; 29: 83-96.
31. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-163.
32. Hope DB. Pyridoxal phosphate as the coenzyme of the mammalian decarboxylase for L-cysteine sulphinic and L-cysteic acids. Biochem J 1955; 59: 497-500.
33. Jacobsen JG, Thomas LL, Smith LH, Jr. Properties and distribution of mammalian L-cysteine sulfinate Carboxy-lyases. Biochim Biophys Acta 1964; 85: 103-116.
34. Reymond I, Bitoun M, Levillain O, Tappaz M. Regional expression and histological localization of cysteine sulfinate decarboxylase mRNA in the rat kidney. J Histochem Cytochem 2000; 48: 1461-1468.
35. Tappaz M, Bitoun M, Reymond I, Sergeant A. Characterization of the cDNA coding for rat brain cysteine sulfinate decarboxylase: brain and liver enzymes are identical proteins encoded by two distinct mRNAs. J Neurochem 1999; 73: 903-912.
36. Li JH, Ling YQ, Fan JJ, Zhang XP, Cui S. Expression of cysteine sulfinate decarboxylase (CSD) in male reproductive organs of mice. Histochem Cell Biol 2006; 125: 607-613.
37. Yang J, Wu G, Feng Y, Sun C, Lin S, Hu J. CSD mRNA expression in rat testis and the effect of taurine on testosterone secretion. Amino Acids 2010; 39: 155-160.
38. Bella DL, Hahn C, Stipanuk MH. Effects of nonsulfur and sulfur amino acids on the regulation of hepatic enzymes of cysteine metabolism. Am J Physiol 1999; 277: E144-153.
39. Ide T. Dietary regulation of hepatic enzymes in taurine biosynthesis in rats. Nutr Biochem 1998; 9: 99-105.
40. Johansson L, Thomsen JS, Damdimopoulos AE, Spyrou G, Gustafsson JA, Treuter E. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta. J Biol Chem 1999; 274: 345-353.
41. Forman BM, Goode E, Chen J etal. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687-693.
42. Alnouti Y, Csanaky IL, Klaassen CD. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 873: 209-217.
43. Butterworth RF. Taurine in hepatic encephalopathy. Adv Exp Med Biol 1996; 403: 601-606.
44. Tang XW, Hsu CC, Schloss JV etal. Protein phosphorylation and taurine biosynthesis in vivo and in vitro. J Neurosci 1997; 17: 6947-6951.
45. Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today 2012; 17: 988-997.